| Dr Agarwal's Health Care Ltd |
|
|
| Initial public offer of up to [*] equity shares of face value of Re. 1 each ("Equity Shares") of Dr. Agarwal's Health Care Limited ("Company") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to Rs. [*] crores comprising a fresh issue of up to [*] equity shares of face value of Re. 1 aggregating up to Rs. 300.00 crores by the company ("Fresh Issue") and an offer for sale of up to 67,842,284 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores ("Offered Shares") by the selling shareholders, consisting of up to 2,176,239 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Amar Agarwal, up to 2,629,829 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by
Athiya Agarwal, up to 3,071,188 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Adil Agarwal, up to 3,614,508 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Anosh Agarwal, up to 241,269 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Ashvin Agarwal, up to 1,883,869 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Agarwal's Eye Institute (collectively "The Promoter Selling Shareholders"), up to 7,083,010 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Arvon Investments Pte. Ltd., up to 16,148,150 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Claymore Investments (Mauritius) Pte. Ltd., and up to 30,755,592 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Hyperion Investments Pte. Ltd. (collectively the "Investor Selling Shareholders"), up to 119,315 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Farah Agarwal, up to 119,315 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Urmila Agarwal (collectively the "Other Selling Shareholders") (the promoter selling shareholders, the other selling shareholders and the investor selling sharehodlers, collectively referred to as the "Selling Shareholders") and such equity shares offered by the selling shareholders ("Offer for Sale", and together with the fresh issue, the "Offer").
The offer includes a reservation of up to 1,579,399 equity shares of face value of Re. 1, aggregating up to Rs. [*] crores (constituting up to [*]% of the post-offer paid-up equity share capital), for subscription by eligible employees ("Employee Reservation Portion") and a reservation of up to 1,129,574 equity shares aggregating up to Rs. [*] crores (constituting up to [*]% of the post-issue paid-up equity share capital) for subscription by eligible aehl shareholders ("Shareholder Reservation Portion"). The offer less the employee reservation portion and the shareholder reservation is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute [*] % and [*] % of the post-offer paid-up equity share capital of the company, respectively.
Price Band: Rs. 382 to Rs. 402 per equity share of face value of Re. 1 each.
The Floor price and Cap price are 382 times and 402 times the face value of the equity shares respectively.
Bids can be made for a minimum of 35 equity shares and in multiple of 35 equity shares thereafter.
|
| Issue |
Money Payable On |
| Opens On |
Closes On |
Offer Price |
Application |
| 29-Jan-25 |
31-Jan-25 |
₹ 382.00-402.00 |
₹ 382.00-402.00 |
| Minimum Application for shares in Nos :35 Further Multiples of :35 |
| |
|
Lead Managers to the Issue |
| Project Cost |
₹ 0.00 Cr |
| Jefferies India Pvt Ltd | | Kotak Mahindra Capital Company Ltd | | Morgan Stanley India Company Pvt Ltd | | Motilal Oswal Investment Advisors Ltd |
|
| Project Financed through Current Offer |
₹ 2891.58 Cr |
|
| Post Issue Equity Share Capital |
₹ 31.59 Cr |
|
| Face Value |
₹ 1 |
|
|
|